Cullinan Oncology, Inc. (CGEM) Stock Surges Following Positive Supplementary CLN-081 Study Information
Cullinan Oncology, Inc. (CGEM) stock prices were up by 18.63% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$35.30 early on in the trading day. CLN-081 Trial Update The oncology company announced supplementary information about Cullinan Pearl’s ongoing Phase 1/2a trial of CLN-081 on June 4th, 2021. […]
CoherusBioSciences, Inc. (CHRS) Stock on the Rise Following Success of JUPITER-02 Pivotal Study
CoherusBioSciences, Inc. (CHRS) stock prices were up by 3.53% shortly after market trading commenced on June 4th, 2021, bringing the price per share up to USD$13.50 early on in the trading day. JUPITER-02 Results The company recently announced the successful results from its pivotal study, JUPITER-02, which was a randomized, double-blind, placebo-controlled Phase 3 clinical […]
Berkeley Lights, Inc. (BLI) Stock Undergoes Minor Volatility as Development of Opto Assure Continues
Berkeley Lights, Inc. (BLI) stock prices were down by 3.18% as of the market closing on May 28th, 2021, bringing the price per share down to USD$43.50 at the end of the trading day. Revenue Reports and Growth in Bases The leader in Digital Cell Biology reported having generated USD$18.6 million in total revenue over […]
Eloxx Pharmaceuticals, Inc. (ELOX) Stock Trending Higher Following Funding Award from Cystic Fibrosis Foundation
Eloxx Pharmaceuticals, Inc. (ELOX) stock prices were up by 5.67% as of the market closing on May 27th, 2021, bringing the price per share up to USD$1.49 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock rise by 7.38%, bringing it up to USD$1.60. Acquisition of Zikani Therapeutics April 1st, […]
AIM ImmunoTech Inc. (AIM) Stock Undergoes Minor Volatility After Announcing Extension of Collaboration with Smoore
AIM ImmunoTech Inc. (AIM) stock prices were down by 1.42% as of the market closing on May 28th, 2021, bringing the price per share down to USD$2.08 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock fall by 2.40%, bringing it down to USD$2.03. Extension of Agreement with Smoore May […]
Lannett Company, Inc. (LCI) Stock Trending Higher Following Development of its Product Pipeline
Lannett Company, Inc. (LCI) stock prices were up by 4.66% a of the market closing on May 27th, 2021, bringing the price per share up to USD$4.94. Refinancing Debt Recent months have seen LCI substantially advance various strategic initiatives, including the company’s successful completion of a transaction in April to refinance their debt. The capital […]
Syros Pharmaceuticals, Inc. (SYRS) Stock on the Rise following Promising Financial Reports for Q1 2021
Syros Pharmaceuticals, Inc. (SYRS) stock prices were up by 17.98% shortly after market trading commenced, bringing the price per share up to USD$6.60 early in the trading day. Revenue Breakdown Revenues for the first quarter of the fiscal year 2021 were reported at USD$4.8 million of which USD$4 million in revenue being recognized under the […]
Purple Biotech Ltd. (PPBT) Stock Undergoes Minor Volatility Amid Progression of CM24 Clinical Trial
Purple Biotech Ltd. (PPBT) stock prices were up by 2.15% as of the market closing on May 26th, 2021, bringing the price per share up to USD$4.76 at the end of the trading day. Subsequent pre-market fluctuations saw the price dip by a marginal 1.05%, bringing it down to USD$4.71. CM24 Trial Commences Patient Dosing […]
Tenax Therapeutics, Inc. (TENX) Stock Undergo Minor Volatility Following Further Development of its Pipeline Candidates
Tenax Therapeutics, Inc. (TENX) stock prices were down by a marginal 0.53% as of the market closing on May 25th, 2021, bringing the price per share down to USD$1.88 at the end of the trading day. R&D Expenses Expenses incurred by research and development during the first quarter of the fiscal year 2021 came out […]
Taiwan Liposome Company, Ltd. (TLC) Stock Soars After Indian Approval for AmphoTLC
Taiwan Liposome Company, Ltd. (TLC) stock prices were up by 34.95% shortly after the market opened on May 25th, 2021, bringing the price per share up to USD$6.68 shortly after the trading day commenced. Indian Approval for AmphoTLC TLC announced on May 25th, 2021 that the Central Drugs Standard Control Organization (CDSCO) of India had […]
